These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7814301)

  • 1. Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study.
    Hori M; Sato H; Karita M; Kodama K; Hoki N; Hayashi T; Naka M; Nanto S; Yamada Y; Kamada T
    Heart Vessels; 1994; 9(5):249-53. PubMed ID: 7814301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
    Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
    PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off.
    Yamada K; Kanba S; Ashikari I; Ohnishi K; Yagi G; Asai M
    J Clin Psychopharmacol; 1996 Dec; 16(6):437-9. PubMed ID: 8959468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure.
    Sato H; Ikenouchi H; Aoyagi T; Matsui H; Mochizuki T; Momomura S; Serizawa T; Iizuka M; Sugimoto T
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):317-22. PubMed ID: 1689429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nilvadipine in hypertension--experience in ambulatory treatment.
    Hoffmann A; Kraul H; Burkardt I
    Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease.
    Takata Y; Yoshizumi T; Ito Y; Kikuchi M; Ueno M; Tsukashima A; Kobayashi K; Fujishima M
    Eur J Clin Pharmacol; 1992; 42(5):475-9. PubMed ID: 1606993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nilvadipine on the cardiovascular responses to tracheal intubation.
    Mikawa K; Maekawa N; Hasegawa M; Kaetsu H; Goto R; Yaku H; Obara H
    J Clin Anesth; 1992; 4(4):292-6. PubMed ID: 1358132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction.
    Udelson JE; DeAbate CA; Berk M; Neuberg G; Packer M; Vijay NK; Gorwitt J; Smith WB; Kukin ML; LeJemtel T; Levine TB; Konstam MA
    Am Heart J; 2000 Mar; 139(3):503-10. PubMed ID: 10689266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
    Honerjäger P; Seibel K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A one year study of single administration of nilvadipine. Results of the effectiveness and long-term tolerance in hypertension].
    Faust G
    Fortschr Med; 1993 Apr; 111(11):188-92. PubMed ID: 8508996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of nisoldipine in chronic congestive heart failure.
    Vogt A; Kreuzer H
    Arzneimittelforschung; 1983; 33(6):877-9. PubMed ID: 6684444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease.
    de Jong DLK; de Heus RAA; Rijpma A; Donders R; Olde Rikkert MGM; Günther M; Lawlor BA; van Osch MJP; Claassen JAHR
    Hypertension; 2019 Aug; 74(2):413-420. PubMed ID: 31203725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension.
    Fritschka E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S62-8. PubMed ID: 1283192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease.
    Lawlor B; Kennelly S; O'Dwyer S; Cregg F; Walsh C; Coen R; Kenny RA; Howard R; Murphy C; Adams J; Daly L; Segurado R; Gaynor S; Crawford F; Mullan M; Lucca U; Banzi R; Pasquier F; Breuilh L; Riepe M; Kalman J; Wallin A; Borjesson A; Molloy W; Tsolaki M; Olde Rikkert M
    BMJ Open; 2014 Oct; 4(10):e006364. PubMed ID: 25300460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.
    Kirch W; Stenzel J; Dylewicz P; Hutt HJ; Santos SR; Ohnhaus EE
    Br J Clin Pharmacol; 1986 Aug; 22(2):155-9. PubMed ID: 3530303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow.
    Meulenbroek O; O'Dwyer S; de Jong D; van Spijker G; Kennelly S; Cregg F; Olde Rikkert M; Abdullah L; Wallin A; Walsh C; Coen R; Kenny RA; Daly L; Segurado R; Borjesson-Hanson A; Crawford F; Mullan M; Lucca U; Banzi R; Pasquier F; Breuilh L; Riepe M; Kalman J; Molloy W; Tsolaki M; Howard R; Adams J; Gaynor S; Lawlor B
    BMJ Open; 2016 Jul; 6(7):e011584. PubMed ID: 27436668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.